Center for Cardiovascular Biology (CCB)


The Metropolitan Atlanta Congenital Defects Program (MACDP), a population-based birth defects surveillance system in Atlanta, recently completed a classification of heart defects in its database. From 1998 to 2005 in the metro Atlanta area there were 398,140 births, of which 3240 infants had CHD, for an overall prevalence of 81.4/10,000 births and other factors may actually cause this to be an underestimation.

While the vast majority of NIH funding for cardiac research is directed toward adult ischemia, atherosclerosis, and heart failure, we have been able to establish a significant group of NIH funded investigators in the areas of imaging, failure, outcomes, and development in CHD.  The early success of our program has propelled us to new heights and initiated a new phase for the Emory+Children’s Center for Cardiovascular Biology. We are now in a time of growth, looking to add expert investigators in critical areas and develop more collaborations with local investigators, and national institutions within the Pediatric Heart Network.

This is also a time to strengthen research within the Center.  By partnering with pediatric cardiologists and cardiothoracic surgeons in the Sibley Heart Center, we will better align the basic research done in the Center with patient-based studies to enable translational research to improve the lives of children with heart disease.

Key Contacts

  • Michael E. Davis, PhD, FAHA

    .(JavaScript must be enabled to view this email address)

  • Mary Wagner, PhD

    .(JavaScript must be enabled to view this email address)

  • Kristen Herzegh, MPH

    .(JavaScript must be enabled to view this email address)